查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1462650

到 2030 年脑积水引流装置市场预测：按产品类型、分流器类型、年龄组、最终用户和地区进行的全球分析

Hydrocephalus Shunt Market Forecasts to 2030 - Global Analysis By Product, Shunt Type, Age Group, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3个工作天内

价格

根据 Stratistics MRC 的数据，2023 年全球脑积水引流装置市场规模为 3.222 亿美元，预计在预测期内将以 6.1% 的复合年增长率增长，并在 2030 年达到 4.876 亿美元。

临床上用于治疗涉及脑脊髓液过多的精神疾病的装置称为脑积水储存脑积水引流装置。颅内压因子增大是颅骨的这种状况的结果。这些设备收集体液有助于减轻大脑的压力。分流器是一种透过手术植入的装置，旨在将多余的脑脊髓液从大脑转移到身体的另一个位置，通常是腹腔，在那里它可以被自然吸收。

根据美国生物化学与分子生物学学会2021年3月发表的论文，美国每年约有280万人遭受创伤性脑损伤（TBI），其中约28万人需要住院治疗。

分流技术的进步

分流技术的进步包括可程式设计和可调节分流系统的开发、使用新材料来提高生物相容性和寿命，以及微创手术技术的引入。可程式设计分流器可在放置分流器后调整流量设置，从而更灵活地管理患者的水脑症。此外，将创新材料纳入分流器设计可提高分流器性能并降低感染和闭塞等併发症的风险。

成本限制

水脑症的特征是脑脊髓液在大脑中储存，通常需要使用分流装置进行手术干预以缓解症状。与分流创建相关的高昂成本，包括手术、装置植入和持续维护，给患者和医疗保健提供者带来了经济负担。但有限的保险覆盖范围，特别是在医疗保健基础设施不足的地区，可能会使问题变得更加复杂，并延迟或拒绝获得基本治疗。

微创手术需求不断成长

与传统开颅手术相比，微创手术具有多种优势，包括减少创伤、恢復时间更快、住院时间更短以及感染和出血等併发症的风险最小化。对于水脑症，通常需要植入分流器来管理过量的脑脊髓液储存，微创方法提供了比传统方法侵入性更小的替代方案。这些手术通常使用较小的切口、专用器械，有时还会使用内视镜引导，以帮助外科医生更精确地放置分流器并最大限度地减少对周围组织的损害。

获得治疗的机会不足

水脑症指脑脊髓液在大脑中储存，通常需要透过分流器进行手术治疗以缓解症状。然而，卫生基础设施的差异，特别是在服务欠缺地区和开发中国家，限制了及时诊断、治疗和后续护理的机会。有限的医疗设施、训练有素的医务人员和财政限制等挑战加剧了这项挑战。因此，许多水脑症患者没有接受必要的分流手术或延迟手术，导致发病率和死亡率增加。

COVID-19 的影响：

随着世界各地的医疗保健系统投入资源对抗这场流行病，包括水脑症手术在内的择期手术被推迟或取消，以优先考虑 COVID-19 患者并最大限度地降低感染风险。这导致分流器植入和置换的减少，导致市场低迷。此外，对非必要医疗程序的限制以及患者因担心感染病毒而不愿去医院的情况进一步减少了需求。

预计在预测期内水脑症导管部分将是最大的

在预测期内，水脑症导管细分市场是市场上最大的细分市场，因为导管设计和材料的进步提高了分流系统的有效性和寿命，改善了患者的治疗效果并减少了翻修手术的需求。先天性水脑症和正常水脑症等疾病的盛行率不断增加，刺激了对有效治疗方案的需求，导致世界脑积水引流装置手术的增加。此外，导管製造的创新促进了微创技术的发展，使分流器置入手术更安全、更容易被病人接受。

脑室腹腔分流部分预计在预测期内复合年增长率最高

脑室分流部分预计将在预测期内实现盈利增长，因为它在治疗水脑症（一种以脑室内脑脊髓液储存为特征的疾病）方面有效且广泛采用。 VP 分流器提供了一种微创解决方案，将多余的液体从脑室转移到腹腔，然后自然吸收到体内。这种方法不仅可以缓解颅内压，还有助于缓解与水脑症，如头痛、噁心和认知障碍。

占比最高的地区

由于神经系统疾病盛行率上升、患者对微创治疗方法的偏好、医疗成本上升以及导致分流技术进步的研发力度不断加大等原因，北美的脑积水引流装置市场正在成长，这是成长最快且成长最快的市场。 占估计期间销售额的最大份额。例如，医疗保险和医疗补助服务中心 (CMS) 预测 2022 年美国医疗保健支出将为 7.5%。预计 2023 年支出将首次超过 1 兆美元。

复合年增长率最高的地区：

由于该地区医疗基础设施的改善、手术数量的增加以及与政府扩大医疗设备组合的协议，预计亚太市场在预测期内将实现盈利增长。例如，2022年3月，日本和印度总理核准了一项五年财政计画和420亿美元的投资，以支持医疗设备製造合资企业。由于医疗成本不断上升，印度医疗保健系统的服务组合正在从护理转向疾病管理的预防保健。

免费客製化服务：

订阅此报告的客户可以存取以下免费自订选项之一：

  • 公司简介
    • 其他市场参与者的综合分析（最多 3 家公司）
    • 主要企业SWOT分析（最多3家企业）
  • 区域分割
    • 根据客户兴趣对主要国家的市场估计、预测和复合年增长率（註：基于可行性检查）
  • 竞争基准化分析
    • 根据产品系列、地理分布和策略联盟对主要企业基准化分析

目录

第一章执行摘要

第二章 前言

  • 概述
  • 相关利益者
  • 调查范围
  • 调查方法
    • 资料探勘
    • 资料分析
    • 资料检验
    • 研究途径
  • 调查来源
    • 主要调查来源
    • 二次研究资料
    • 先决条件

第三章市场趋势分析

  • 促进因素
  • 抑制因素
  • 机会
  • 威胁
  • 产品分析
  • 最终用户分析
  • 新兴市场
  • COVID-19 的影响

第4章波特五力分析

  • 供应商的议价能力
  • 买方议价能力
  • 替代品的威胁
  • 新进入者的威胁
  • 竞争公司之间的敌对关係

第五章全球脑积水引流装置市场：副产品

  • 水脑症导管
    • 抗菌导管
    • 标准导管
  • 水脑症瓣膜
    • 定压阀
    • 可调压力阀
  • 其他产品

第六章全球脑积水引流装置市场：依分流器类型

  • 脑室胸膜分流术
  • 腰部腹腔分流术
  • 心房分流术
  • 脑室腹腔分流术
  • 其他分流器类型

第七章全球脑积水引流装置市场：依年龄族群

  • 成人
  • 儿童

第八章全球脑积水引流装置市场：依最终用户分类

  • 门诊手术中心
  • 医院
  • 其他最终用户

第九章全球脑积水引流装置市场：按地区

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 义大利
    • 法国
    • 西班牙
    • 其他欧洲国家
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 纽西兰
    • 韩国
    • 其他亚太地区
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地区
  • 中东/非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 卡达
    • 南非
    • 其他中东和非洲

第10章 主要进展

  • 合约、伙伴关係、协作和合资企业
  • 收购和合併
  • 新产品发布
  • 业务扩展
  • 其他关键策略

第十一章 公司概况

  • Aesculap, Inc
  • B. Braun Melsungen AG
  • Christoph Miethke GmbH & Co. KG
  • G. Surgiwear Ltd
  • Integra LifeSciences
  • Johnson & Johnson
  • Medtronic
  • Natus Medical Incorporated
  • Sophysa
  • Spiegelberg GmbH & Co. KG
Product Code: SMRC25701

According to Stratistics MRC, the Global Hydrocephalus Shunt Market is accounted for $322.2 million in 2023 and is expected to reach $487.6 million by 2030 growing at a CAGR of 6.1% during the forecast period. An apparatus used in clinical practice to help treat a mental illness involving excessive cerebrospinal fluid collection is referred to as a hydrocephalus shunt. An expanded intracranial pressing factor is the result of this condition in the skull. The fluid collection caused by these devices helps reduce stress in the brain. Shunts are surgically implanted devices designed to divert excess cerebrospinal fluid from the brain to another part of the body, typically the abdominal cavity, where it can be absorbed naturally.

According to an article published by the American Society for Biochemistry and Molecular Biology in March 2021, in the United States, about 2.8 million people sustain a traumatic brain injury (TBI) every year, with some 280,000 resulting in hospitalizations.

Market Dynamics:

Driver:

Advancements in shunt technology

The advancements encompass a wide range of improvements, including the development of programmable and adjustable shunt systems, utilization of novel materials for improved biocompatibility and longevity, and the introduction of minimally invasive surgical techniques. Programmable shunts offer the ability to adjust flow settings post-implantation, providing greater flexibility in managing patients' hydrocephalus symptoms. Additionally, the integration of innovative materials into shunt designs enhances their performance and reduces the risk of complications such as infection and blockage.

Restraint:

Cost constraints

Hydrocephalus, a condition characterized by an accumulation of cerebrospinal fluid in the brain, often requires surgical intervention with shunt devices to alleviate symptoms. The high cost associated with shunt placement, including surgery, device implantation, and ongoing maintenance, poses financial burdens for patients and healthcare providers alike. However, limited insurance coverage, particularly in regions with inadequate healthcare infrastructure, further exacerbates the issue, potentially delaying or denying access to essential treatment.

Opportunity:

Growing demand for minimally invasive surgical procedures

Minimally invasive techniques offer several advantages over traditional open surgeries, including reduced trauma, faster recovery times, shorter hospital stays, and minimized risk of complications such as infection and bleeding. In the context of hydrocephalus, where patients often require shunt implantation to manage excess cerebrospinal fluid buildup, minimally invasive approaches provide a less invasive alternative to traditional methods. These techniques typically involve smaller incisions, specialized tools, and sometimes even endoscopic guidance, allowing surgeons to place shunts with greater precision and minimal disruption to surrounding tissues.

Threat:

Inadequate access to care

Hydrocephalus, a condition characterized by an accumulation of cerebrospinal fluid within the brain, often requires surgical intervention with shunts to alleviate symptoms. However, disparities in healthcare infrastructure, particularly in underserved regions and developing countries, limit access to timely diagnosis, treatment, and follow-up care. Factors such as limited healthcare facilities, insufficient trained medical personnel, and financial constraints contribute to this challenge. Consequently, many individuals with hydrocephalus lack access to essential shunt surgeries or experience delays in receiving them, leading to increased morbidity and mortality rates.

Covid-19 Impact:

As healthcare systems worldwide redirected resources to combat the pandemic, elective surgeries, including those for hydrocephalus, were postponed or canceled to prioritize COVID-19 patients and minimize transmission risks. This led to a decrease in shunt implantations and replacements, resulting in a downturn in the market. Moreover, restrictions on non-essential medical procedures, coupled with patients' reluctance to visit hospitals due to fear of contracting the virus, further dampened demand.

The Hydrocephalus Catheter segment is expected to be the largest during the forecast period

Hydrocephalus Catheter segment commanded the largest share of the market over the projection period as advancements in catheter design and materials have improved the efficacy and longevity of shunt systems, enhancing patient outcomes and reducing the need for revision surgeries. The increasing prevalence of conditions such as congenital hydrocephalus and normal pressure hydrocephalus is fueling demand for effective treatment options, leading to a rising number of hydrocephalus shunt procedures worldwide. Moreover, technological innovations in catheter manufacturing have allowed for the development of minimally invasive techniques, making shunt placement procedures safer and more accessible to patients.

The Ventriculoperitoneal Shunts segment is expected to have the highest CAGR during the forecast period

Ventriculoperitoneal Shunts segment is poised to witness profitable growth during the overcast period due to its effectiveness and widespread adoption in treating hydrocephalus-a condition characterized by the accumulation of cerebrospinal fluid in the brain's ventricles. VP shunts offer a minimally invasive solution by diverting excess fluid from the brain's ventricles to the peritoneal cavity, where it can be naturally absorbed by the body. This approach not only relieves intracranial pressure but also helps alleviate symptoms associated with hydrocephalus, such as headaches, nausea, and cognitive impairment.

Region with largest share:

Because of the rising prevalence of neurological disorders, patients' preference for less invasive procedures, rising healthcare costs, and improved research and development efforts leading to advancements in shunt technology, the hydrocephalus shunts market has grown most rapidly in North America, accounting for the largest revenue share over the extrapolated period. The Centers for Medicare & Medicaid Services (CMS), for instance, projected that in 2022, health spending in the United States would be 7.5%. The first time that spending is expected to surpass $1 trillion USD is in 2023.

Region with highest CAGR:

Because of the region's improved healthcare infrastructure, rising number of surgeries, and government agreements to expand the medical device portfolio, the Asia Pacific market is expected to grow profitably over the projected period. For instance, the prime ministers of Japan and India approved a five-year financial plan and an investment of USD 42 billion in March 2022 to support a joint venture in medical equipment production. Due to rising healthcare costs, India's healthcare system is witnessing a shift in its service portfolio from nursing care to preventative care for disease control.

Key players in the market

Some of the key players in Hydrocephalus Shunt market include Aesculap, Inc, B. Braun Melsungen AG, Christoph Miethke GmbH & Co. KG, G. Surgiwear Ltd, Integra LifeSciences, Johnson & Johnson, Medtronic, Natus Medical Incorporated, Sophysa and Spiegelberg GmbH & Co. KG.

Key Developments:

In November 2023, for young patients suffering from hydrocephalus-a neurological disorder that results in an accumulation of cerebral fluid in the interior spaces of the brain which often requires repeated hospital stays-surgeons at Intermountain Primary Children's Hospital successfully placed a novel brain shunt accessory, becoming the first hospital in the U.S. to accomplish the same.

In October 2023, through its Blueprint MedTech initiative, the NINDS (National Institute of Neurological Disorders and Stroke) of the National Institutes of Health (NIH) awarded Rhaeos, Inc. a USD 1.5 million grant. With this award, the company will continue to develop its FDA-designated breakthrough medical technology, which aims to revolutionize the treatment of hydrocephalus, a brain disorder that affects more than a million people in the U.S.

In July 2023, Cerevasc Inc. partnered with Lianmedical Co. Ltd. to introduce its medical devices for neurological diseases in Asia. Lianmedical marketed Cerevasc's eshunt system and related products in mainland China, Hong Kong, Taiwan, and Macau, facilitating percutaneous transvenous-transdural access to the central nervous system.

Products Covered:

  • Hydrocephalus Catheter
  • Hydrocephalus Valves
  • Other Products

Shunt Types Covered:

  • Ventriculopleural Shunts
  • Lumboperitoneal Shunts
  • Ventriculoatrial Shunts
  • Ventriculoperitoneal Shunts
  • Other Shunt Types

Age Groups Covered:

  • Adult
  • Pediatric

End Users Covered:

  • Ambulatory Surgical Centers
  • Hospitals
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 End User Analysis
  • 3.8 Emerging Markets
  • 3.9 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Hydrocephalus Shunt Market, By Product

  • 5.1 Introduction
  • 5.2 Hydrocephalus Catheter
    • 5.2.1 Antimicrobial Catheters
    • 5.2.2 Standard Catheters
  • 5.3 Hydrocephalus Valves
    • 5.3.1 Fix Pressure Valves
    • 5.3.2 Adjustable Pressure Valves
  • 5.4 Other Products

6 Global Hydrocephalus Shunt Market, By Shunt Type

  • 6.1 Introduction
  • 6.2 Ventriculopleural Shunts
  • 6.3 Lumboperitoneal Shunts
  • 6.4 Ventriculoatrial Shunts
  • 6.5 Ventriculoperitoneal Shunts
  • 6.6 Other Shunt Types

7 Global Hydrocephalus Shunt Market, By Age Group

  • 7.1 Introduction
  • 7.2 Adult
  • 7.3 Pediatric

8 Global Hydrocephalus Shunt Market, By End User

  • 8.1 Introduction
  • 8.2 Ambulatory Surgical Centers
  • 8.3 Hospitals
  • 8.4 Other End Users

9 Global Hydrocephalus Shunt Market, By Geography

  • 9.1 Introduction
  • 9.2 North America
    • 9.2.1 US
    • 9.2.2 Canada
    • 9.2.3 Mexico
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 Italy
    • 9.3.4 France
    • 9.3.5 Spain
    • 9.3.6 Rest of Europe
  • 9.4 Asia Pacific
    • 9.4.1 Japan
    • 9.4.2 China
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 New Zealand
    • 9.4.6 South Korea
    • 9.4.7 Rest of Asia Pacific
  • 9.5 South America
    • 9.5.1 Argentina
    • 9.5.2 Brazil
    • 9.5.3 Chile
    • 9.5.4 Rest of South America
  • 9.6 Middle East & Africa
    • 9.6.1 Saudi Arabia
    • 9.6.2 UAE
    • 9.6.3 Qatar
    • 9.6.4 South Africa
    • 9.6.5 Rest of Middle East & Africa

10 Key Developments

  • 10.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 10.2 Acquisitions & Mergers
  • 10.3 New Product Launch
  • 10.4 Expansions
  • 10.5 Other Key Strategies

11 Company Profiling

  • 11.1 Aesculap, Inc
  • 11.2 B. Braun Melsungen AG
  • 11.3 Christoph Miethke GmbH & Co. KG
  • 11.4 G. Surgiwear Ltd
  • 11.5 Integra LifeSciences
  • 11.6 Johnson & Johnson
  • 11.7 Medtronic
  • 11.8 Natus Medical Incorporated
  • 11.9 Sophysa
  • 11.10 Spiegelberg GmbH & Co. KG

List of Tables

  • Table 1 Global Hydrocephalus Shunt Market Outlook, By Region (2021-2030) ($MN)
  • Table 2 Global Hydrocephalus Shunt Market Outlook, By Product (2021-2030) ($MN)
  • Table 3 Global Hydrocephalus Shunt Market Outlook, By Hydrocephalus Catheter (2021-2030) ($MN)
  • Table 4 Global Hydrocephalus Shunt Market Outlook, By Antimicrobial Catheters (2021-2030) ($MN)
  • Table 5 Global Hydrocephalus Shunt Market Outlook, By Standard Catheters (2021-2030) ($MN)
  • Table 6 Global Hydrocephalus Shunt Market Outlook, By Hydrocephalus Valves (2021-2030) ($MN)
  • Table 7 Global Hydrocephalus Shunt Market Outlook, By Fix Pressure Valves (2021-2030) ($MN)
  • Table 8 Global Hydrocephalus Shunt Market Outlook, By Adjustable Pressure Valves (2021-2030) ($MN)
  • Table 9 Global Hydrocephalus Shunt Market Outlook, By Other Products (2021-2030) ($MN)
  • Table 10 Global Hydrocephalus Shunt Market Outlook, By Shunt Type (2021-2030) ($MN)
  • Table 11 Global Hydrocephalus Shunt Market Outlook, By Ventriculopleural Shunts (2021-2030) ($MN)
  • Table 12 Global Hydrocephalus Shunt Market Outlook, By Lumboperitoneal Shunts (2021-2030) ($MN)
  • Table 13 Global Hydrocephalus Shunt Market Outlook, By Ventriculoatrial Shunts (2021-2030) ($MN)
  • Table 14 Global Hydrocephalus Shunt Market Outlook, By Ventriculoperitoneal Shunts (2021-2030) ($MN)
  • Table 15 Global Hydrocephalus Shunt Market Outlook, By Other Shunt Types (2021-2030) ($MN)
  • Table 16 Global Hydrocephalus Shunt Market Outlook, By Age Group (2021-2030) ($MN)
  • Table 17 Global Hydrocephalus Shunt Market Outlook, By Adult (2021-2030) ($MN)
  • Table 18 Global Hydrocephalus Shunt Market Outlook, By Pediatric (2021-2030) ($MN)
  • Table 19 Global Hydrocephalus Shunt Market Outlook, By End User (2021-2030) ($MN)
  • Table 20 Global Hydrocephalus Shunt Market Outlook, By Ambulatory Surgical Centers (2021-2030) ($MN)
  • Table 21 Global Hydrocephalus Shunt Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 22 Global Hydrocephalus Shunt Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 23 North America Hydrocephalus Shunt Market Outlook, By Country (2021-2030) ($MN)
  • Table 24 North America Hydrocephalus Shunt Market Outlook, By Product (2021-2030) ($MN)
  • Table 25 North America Hydrocephalus Shunt Market Outlook, By Hydrocephalus Catheter (2021-2030) ($MN)
  • Table 26 North America Hydrocephalus Shunt Market Outlook, By Antimicrobial Catheters (2021-2030) ($MN)
  • Table 27 North America Hydrocephalus Shunt Market Outlook, By Standard Catheters (2021-2030) ($MN)
  • Table 28 North America Hydrocephalus Shunt Market Outlook, By Hydrocephalus Valves (2021-2030) ($MN)
  • Table 29 North America Hydrocephalus Shunt Market Outlook, By Fix Pressure Valves (2021-2030) ($MN)
  • Table 30 North America Hydrocephalus Shunt Market Outlook, By Adjustable Pressure Valves (2021-2030) ($MN)
  • Table 31 North America Hydrocephalus Shunt Market Outlook, By Other Products (2021-2030) ($MN)
  • Table 32 North America Hydrocephalus Shunt Market Outlook, By Shunt Type (2021-2030) ($MN)
  • Table 33 North America Hydrocephalus Shunt Market Outlook, By Ventriculopleural Shunts (2021-2030) ($MN)
  • Table 34 North America Hydrocephalus Shunt Market Outlook, By Lumboperitoneal Shunts (2021-2030) ($MN)
  • Table 35 North America Hydrocephalus Shunt Market Outlook, By Ventriculoatrial Shunts (2021-2030) ($MN)
  • Table 36 North America Hydrocephalus Shunt Market Outlook, By Ventriculoperitoneal Shunts (2021-2030) ($MN)
  • Table 37 North America Hydrocephalus Shunt Market Outlook, By Other Shunt Types (2021-2030) ($MN)
  • Table 38 North America Hydrocephalus Shunt Market Outlook, By Age Group (2021-2030) ($MN)
  • Table 39 North America Hydrocephalus Shunt Market Outlook, By Adult (2021-2030) ($MN)
  • Table 40 North America Hydrocephalus Shunt Market Outlook, By Pediatric (2021-2030) ($MN)
  • Table 41 North America Hydrocephalus Shunt Market Outlook, By End User (2021-2030) ($MN)
  • Table 42 North America Hydrocephalus Shunt Market Outlook, By Ambulatory Surgical Centers (2021-2030) ($MN)
  • Table 43 North America Hydrocephalus Shunt Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 44 North America Hydrocephalus Shunt Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 45 Europe Hydrocephalus Shunt Market Outlook, By Country (2021-2030) ($MN)
  • Table 46 Europe Hydrocephalus Shunt Market Outlook, By Product (2021-2030) ($MN)
  • Table 47 Europe Hydrocephalus Shunt Market Outlook, By Hydrocephalus Catheter (2021-2030) ($MN)
  • Table 48 Europe Hydrocephalus Shunt Market Outlook, By Antimicrobial Catheters (2021-2030) ($MN)
  • Table 49 Europe Hydrocephalus Shunt Market Outlook, By Standard Catheters (2021-2030) ($MN)
  • Table 50 Europe Hydrocephalus Shunt Market Outlook, By Hydrocephalus Valves (2021-2030) ($MN)
  • Table 51 Europe Hydrocephalus Shunt Market Outlook, By Fix Pressure Valves (2021-2030) ($MN)
  • Table 52 Europe Hydrocephalus Shunt Market Outlook, By Adjustable Pressure Valves (2021-2030) ($MN)
  • Table 53 Europe Hydrocephalus Shunt Market Outlook, By Other Products (2021-2030) ($MN)
  • Table 54 Europe Hydrocephalus Shunt Market Outlook, By Shunt Type (2021-2030) ($MN)
  • Table 55 Europe Hydrocephalus Shunt Market Outlook, By Ventriculopleural Shunts (2021-2030) ($MN)
  • Table 56 Europe Hydrocephalus Shunt Market Outlook, By Lumboperitoneal Shunts (2021-2030) ($MN)
  • Table 57 Europe Hydrocephalus Shunt Market Outlook, By Ventriculoatrial Shunts (2021-2030) ($MN)
  • Table 58 Europe Hydrocephalus Shunt Market Outlook, By Ventriculoperitoneal Shunts (2021-2030) ($MN)
  • Table 59 Europe Hydrocephalus Shunt Market Outlook, By Other Shunt Types (2021-2030) ($MN)
  • Table 60 Europe Hydrocephalus Shunt Market Outlook, By Age Group (2021-2030) ($MN)
  • Table 61 Europe Hydrocephalus Shunt Market Outlook, By Adult (2021-2030) ($MN)
  • Table 62 Europe Hydrocephalus Shunt Market Outlook, By Pediatric (2021-2030) ($MN)
  • Table 63 Europe Hydrocephalus Shunt Market Outlook, By End User (2021-2030) ($MN)
  • Table 64 Europe Hydrocephalus Shunt Market Outlook, By Ambulatory Surgical Centers (2021-2030) ($MN)
  • Table 65 Europe Hydrocephalus Shunt Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 66 Europe Hydrocephalus Shunt Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 67 Asia Pacific Hydrocephalus Shunt Market Outlook, By Country (2021-2030) ($MN)
  • Table 68 Asia Pacific Hydrocephalus Shunt Market Outlook, By Product (2021-2030) ($MN)
  • Table 69 Asia Pacific Hydrocephalus Shunt Market Outlook, By Hydrocephalus Catheter (2021-2030) ($MN)
  • Table 70 Asia Pacific Hydrocephalus Shunt Market Outlook, By Antimicrobial Catheters (2021-2030) ($MN)
  • Table 71 Asia Pacific Hydrocephalus Shunt Market Outlook, By Standard Catheters (2021-2030) ($MN)
  • Table 72 Asia Pacific Hydrocephalus Shunt Market Outlook, By Hydrocephalus Valves (2021-2030) ($MN)
  • Table 73 Asia Pacific Hydrocephalus Shunt Market Outlook, By Fix Pressure Valves (2021-2030) ($MN)
  • Table 74 Asia Pacific Hydrocephalus Shunt Market Outlook, By Adjustable Pressure Valves (2021-2030) ($MN)
  • Table 75 Asia Pacific Hydrocephalus Shunt Market Outlook, By Other Products (2021-2030) ($MN)
  • Table 76 Asia Pacific Hydrocephalus Shunt Market Outlook, By Shunt Type (2021-2030) ($MN)
  • Table 77 Asia Pacific Hydrocephalus Shunt Market Outlook, By Ventriculopleural Shunts (2021-2030) ($MN)
  • Table 78 Asia Pacific Hydrocephalus Shunt Market Outlook, By Lumboperitoneal Shunts (2021-2030) ($MN)
  • Table 79 Asia Pacific Hydrocephalus Shunt Market Outlook, By Ventriculoatrial Shunts (2021-2030) ($MN)
  • Table 80 Asia Pacific Hydrocephalus Shunt Market Outlook, By Ventriculoperitoneal Shunts (2021-2030) ($MN)
  • Table 81 Asia Pacific Hydrocephalus Shunt Market Outlook, By Other Shunt Types (2021-2030) ($MN)
  • Table 82 Asia Pacific Hydrocephalus Shunt Market Outlook, By Age Group (2021-2030) ($MN)
  • Table 83 Asia Pacific Hydrocephalus Shunt Market Outlook, By Adult (2021-2030) ($MN)
  • Table 84 Asia Pacific Hydrocephalus Shunt Market Outlook, By Pediatric (2021-2030) ($MN)
  • Table 85 Asia Pacific Hydrocephalus Shunt Market Outlook, By End User (2021-2030) ($MN)
  • Table 86 Asia Pacific Hydrocephalus Shunt Market Outlook, By Ambulatory Surgical Centers (2021-2030) ($MN)
  • Table 87 Asia Pacific Hydrocephalus Shunt Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 88 Asia Pacific Hydrocephalus Shunt Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 89 South America Hydrocephalus Shunt Market Outlook, By Country (2021-2030) ($MN)
  • Table 90 South America Hydrocephalus Shunt Market Outlook, By Product (2021-2030) ($MN)
  • Table 91 South America Hydrocephalus Shunt Market Outlook, By Hydrocephalus Catheter (2021-2030) ($MN)
  • Table 92 South America Hydrocephalus Shunt Market Outlook, By Antimicrobial Catheters (2021-2030) ($MN)
  • Table 93 South America Hydrocephalus Shunt Market Outlook, By Standard Catheters (2021-2030) ($MN)
  • Table 94 South America Hydrocephalus Shunt Market Outlook, By Hydrocephalus Valves (2021-2030) ($MN)
  • Table 95 South America Hydrocephalus Shunt Market Outlook, By Fix Pressure Valves (2021-2030) ($MN)
  • Table 96 South America Hydrocephalus Shunt Market Outlook, By Adjustable Pressure Valves (2021-2030) ($MN)
  • Table 97 South America Hydrocephalus Shunt Market Outlook, By Other Products (2021-2030) ($MN)
  • Table 98 South America Hydrocephalus Shunt Market Outlook, By Shunt Type (2021-2030) ($MN)
  • Table 99 South America Hydrocephalus Shunt Market Outlook, By Ventriculopleural Shunts (2021-2030) ($MN)
  • Table 100 South America Hydrocephalus Shunt Market Outlook, By Lumboperitoneal Shunts (2021-2030) ($MN)
  • Table 101 South America Hydrocephalus Shunt Market Outlook, By Ventriculoatrial Shunts (2021-2030) ($MN)
  • Table 102 South America Hydrocephalus Shunt Market Outlook, By Ventriculoperitoneal Shunts (2021-2030) ($MN)
  • Table 103 South America Hydrocephalus Shunt Market Outlook, By Other Shunt Types (2021-2030) ($MN)
  • Table 104 South America Hydrocephalus Shunt Market Outlook, By Age Group (2021-2030) ($MN)
  • Table 105 South America Hydrocephalus Shunt Market Outlook, By Adult (2021-2030) ($MN)
  • Table 106 South America Hydrocephalus Shunt Market Outlook, By Pediatric (2021-2030) ($MN)
  • Table 107 South America Hydrocephalus Shunt Market Outlook, By End User (2021-2030) ($MN)
  • Table 108 South America Hydrocephalus Shunt Market Outlook, By Ambulatory Surgical Centers (2021-2030) ($MN)
  • Table 109 South America Hydrocephalus Shunt Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 110 South America Hydrocephalus Shunt Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 111 Middle East & Africa Hydrocephalus Shunt Market Outlook, By Country (2021-2030) ($MN)
  • Table 112 Middle East & Africa Hydrocephalus Shunt Market Outlook, By Product (2021-2030) ($MN)
  • Table 113 Middle East & Africa Hydrocephalus Shunt Market Outlook, By Hydrocephalus Catheter (2021-2030) ($MN)
  • Table 114 Middle East & Africa Hydrocephalus Shunt Market Outlook, By Antimicrobial Catheters (2021-2030) ($MN)
  • Table 115 Middle East & Africa Hydrocephalus Shunt Market Outlook, By Standard Catheters (2021-2030) ($MN)
  • Table 116 Middle East & Africa Hydrocephalus Shunt Market Outlook, By Hydrocephalus Valves (2021-2030) ($MN)
  • Table 117 Middle East & Africa Hydrocephalus Shunt Market Outlook, By Fix Pressure Valves (2021-2030) ($MN)
  • Table 118 Middle East & Africa Hydrocephalus Shunt Market Outlook, By Adjustable Pressure Valves (2021-2030) ($MN)
  • Table 119 Middle East & Africa Hydrocephalus Shunt Market Outlook, By Other Products (2021-2030) ($MN)
  • Table 120 Middle East & Africa Hydrocephalus Shunt Market Outlook, By Shunt Type (2021-2030) ($MN)
  • Table 121 Middle East & Africa Hydrocephalus Shunt Market Outlook, By Ventriculopleural Shunts (2021-2030) ($MN)
  • Table 122 Middle East & Africa Hydrocephalus Shunt Market Outlook, By Lumboperitoneal Shunts (2021-2030) ($MN)
  • Table 123 Middle East & Africa Hydrocephalus Shunt Market Outlook, By Ventriculoatrial Shunts (2021-2030) ($MN)
  • Table 124 Middle East & Africa Hydrocephalus Shunt Market Outlook, By Ventriculoperitoneal Shunts (2021-2030) ($MN)
  • Table 125 Middle East & Africa Hydrocephalus Shunt Market Outlook, By Other Shunt Types (2021-2030) ($MN)
  • Table 126 Middle East & Africa Hydrocephalus Shunt Market Outlook, By Age Group (2021-2030) ($MN)
  • Table 127 Middle East & Africa Hydrocephalus Shunt Market Outlook, By Adult (2021-2030) ($MN)
  • Table 128 Middle East & Africa Hydrocephalus Shunt Market Outlook, By Pediatric (2021-2030) ($MN)
  • Table 129 Middle East & Africa Hydrocephalus Shunt Market Outlook, By End User (2021-2030) ($MN)
  • Table 130 Middle East & Africa Hydrocephalus Shunt Market Outlook, By Ambulatory Surgical Centers (2021-2030) ($MN)
  • Table 131 Middle East & Africa Hydrocephalus Shunt Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 132 Middle East & Africa Hydrocephalus Shunt Market Outlook, By Other End Users (2021-2030) ($MN)